secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapForce Inc. (CFOR)
CIK:        0001293818
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0001079973-23-000502
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OpGen signs non-exclusive distribution deal with Fisher Healthcare for Unyvero platform in U.S.
--------------------------------------------------------------------------------

- Fisher Healthcare becomes non-exclusive national distributor for Unyvero A50 platform alongside OpGen's direct U.S. sales.
- Initial focus on FDA-cleared Unyvero LRT (BAL) cartridge for hospitalized pneumonia patients and RUO Unyvero UTI for UTIs.
- Unyvero LRT is first FDA-cleared IVD for bacterial pneumonia and antimicrobial resistance markers.
- Unyvero UTI pivotal trial completed; De Novo classification request submitted to FDA.
- Deal aims to expand Unyvero commercial presence and drive revenue growth in the U.S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293818/000107997323000502/0001079973-23-000502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293818/000107997323000502/opgen_8k-041923.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-000502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer